Alternate Text DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC23192 Rhosin hydrochloride Featured Rhosin (G04) is a potent, specific RhoA subfamily Rho GTPases inhibitor that specifically binds to RhoA to inhibit GEF reaction of RhoA with Kd of 0.4 uM, does not interact with Cdc42 or Rac1, nor the LARG.
DC9881 RHPS4 Featured RHPS4 is a potent inhibitor of Telomerase at submicromolar.
DC7264 RI-1 Featured RI-1 is a RAD51 inhibitor with IC50 ranging from 5 to 30 μM.
DC8226 RI-2 Featured RI-2 is an optimized RAD51 inhibitor with an IC50 of 44.17 μM in the standard DNA binding assay; specifically inhibits HR(Homologous recombination) repair in human cells.
DCAPI1165 Ribavirin (Copegus) Featured Ribavirin is a guanosine analog with antiviral properties against DNA and RNA viruses, including respiratory syncytial virus, hepatitis C, and influenza.
DC24015 Ribocil Featured Ribocil is a synthetic mimic of riboflavin 5’-monophosphate (FMN) that competes with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB.
DC12237 Riboflavine phosphate (Riboflavine 5'-phosphate) Riboflavine phosphate is a very effective NAD+-recycling agent.
DCAPI1325 Rifabutin (Mycobutin) Rifabutin (Mycobutin)
DCAPI1283 Rifapentine (Priftin) Rifapentine (Priftin)
DC23909 Rifaximin Rifaximin is an oral, semi-synthetic antibiotic derived from Rifamycin SV with antibacterial activity, interferes with transcription by binding to the β-subunit of bacterial RNA polymerase.
DCAPI1446 rifomycins rifomycins
DC7265 Rigosertib Featured Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM; shows 30-fold greater selectivity against PLK2 and no activity to PLK3.
DC24085 Rigosertib sodium Featured Rigosertib sodium (ON 01910.Na) is a potent, non-ATP-competitive PLK1 inhibitor (IC50=9-10 nM), selectively induces mitotic G2/M arrest and apoptosis in cancer cells.
DC7266 Rilpivirine(R 278474, TMC 278) Featured Rilpivirine(R 278474, TMC 278) is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI).
DC8985 Riluzole Featured Riluzole is a glutamate antagonist used as an anticonvulsant and to prolong the survival of patients with amyotrophic lateral sclerosis.
DCAPI1057 Rimantadine (Flumadine) Rimantadine (Flumadine)
DC12800 BMS-927711(Rimegepant) Featured Rimegepant (BMS-927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.
DC22089 Rimeporide (EMD-87580) Rimeporide (EMD87580) is a potent, selective sodium hydrogen exchanger NHE1 inhibitor, show promise as potential therapeutic agents for the treatment of heart failure..
DC9383 Rimonabant (Hydrochloride) Featured Rimonabant Hcl(SR141716A) is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.
DC8876 Rimonabant(SR141716) Featured Rimonabant(SR141716) is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.
DC7267 Riociguat (BAY 63-2521) Featured Riociguat (BAY 63-2521) is a stimulator of soluble guanylate cyclase (sGC).
DC20535 RIP1-IN-22 RIP1-IN-22 is a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor with pKi of 9.04.
DC10389 RIPA-56 Featured RIPA-56 is a highly potent, selective, and metabolically stable inhibitor of receptor-interacting protein 1 (RIP1) with an IC50 of 13 nM.
DC21945 RIPGBM RIPGBM is a cell type-selective, small molecule inducer of apoptosis in GBM cancer stem cells (CSCs) with EC50 of 220 nM (GBM 1 cells).
DC20536 RIPK2 inhibitor 1 RIPK2 inhibitor 1 is a novel potent, selective RIPK2 inhibitor with IC50 of 5-10 nM.
DC21946 RIPK2 inhibitor OD36 RIPK2 inhibitor OD36 is a potent, specific, ATP-competitive inhibitor of RIPK2 with IC50 of 5.3 nM, inhibits Tyr and Ser/Thr-directed activities of RIPK2.
DC21563 Risdiplam Featured Risdiplam (RG7916, RG-7916, RO7034067) is a highly potent, selective, orally active SMN2 splicing modifier for treatment of spinal muscular atrophy (SMA).
DC9049 Risedronate Sodium Risedronate sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption.
DCAPI1012 Risedronic acid (Actonel) Risedronic acid (Actonel)
DC23619 Rislenemdaz hydrochloride Rislenemdaz (MK 0657.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X